S-nitrosylation: Integrator of cardiovascular performance and oxygen delivery

Journal of Clinical Investigation

Volumn 123, Issue 1, 2013, Pages 101-110

  Haldar, Saptarsi M ^a   Stamler, Jonathan S ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 2; DYNAMIN; G PROTEIN COUPLED RECEPTOR KINASE 2; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; OXYGEN; RYANODINE RECEPTOR 1; RYANODINE RECEPTOR 2; S NITROSOTHIOL; THIOREDOXIN;

ACETYLATION; AIR CONDITIONING; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CELL FUNCTION; CONCEPTUAL FRAMEWORK; ENZYME ACTIVITY; HEART MUSCLE; HOMEOSTASIS; HUMAN; HYPOXEMIA; LUNG VENTILATION; MUSCLE FUNCTION; NITROSYLATION; OXYGEN CONCENTRATION; OXYGEN CONSUMPTION; OXYGEN SENSING; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; TISSUE OXYGENATION; UBIQUITINATION;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CARDIOVASCULAR DISEASES; HUMANS; NITRIC OXIDE; OXYGEN;

EID: 84873812945     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI62854     Document Type: Review

References (127)

1. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148(3): 399-408.
2. Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30(4): 393-402.
3. McMahon TJ, et al. Nitric oxide in the human respiratory cycle. Nat Med. 2002;8(7): 711-717.
4. Stamler JS, et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 1997;276(5321): 2034-2037.
5. Ho JJ, Man HS, Marsden PA. Nitric oxide signaling in hypoxia. J Mol Med (Berl). 2012;90(3): 217-231.
6. Janssen-Heininger YM, et al. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med. 2008;45(1): 1-17.
7. Stamler JS, et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A. 1992;89(1): 444-448.
8. Hess DT, et al. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol. 2005;6(2): 150-166.
9. Anand P, Stamler JS. Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease. J Mol Med (Berl). 2012;90(3): 233-244.
10. Doctor A, Stamler JS. Nitric oxide transport in blood: a third gas in the respiratory cycle. In: Comprehensive Physiology. Vol. 1, Iss. 1. Hoboken, New Jersey, USA: John Wiley and Sons; 2011: 541-568.
11. Lima B, Forrester MT, Hess DT, Stamler JS. S-nitrosylation in cardiovascular signaling. Circ Res. 2010;106(4): 633-646.
12. Foster MW, Hess DT, Stamler JS. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med. 2009;15(9): 391-404.
13. Kohr MJ, et al. Characterization of potential S-nitrosylation sites in the myocardium. Am J Physiol Heart Circ Physiol. 2011;300(4):H1327-H1335.
14. Kohr MJ, et al. Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture. Circ Res. 2011;108(4): 418-426.
15. Hess DT, Stamler JS. Regulation by S-nitrosylation of protein post-translational modification. J Biol Chem. 2012;287(7): 4411-4418.
16. Seth D, Hausladen A, Wang YJ, Stamler JS. Endogenous protein S-Nitrosylation in E. coli: regulation by OxyR. Science. 2012;336(6080): 470-473.
17. Finkel T. Signal transduction by reactive oxygen species. J Cell Biol. 2011;194(1): 7-15.
18. Luchsinger BP, Rich EN, Gow AJ, Williams EM, Stamler JS, Singel DJ. Routes to S-nitroso-hemoglobin formation with heme redox and preferential reactivity in the beta subunits. Proc Natl Acad Sci U S A. 2003;100(2): 461-466.
19. Lundberg JO, et al. Nitrate and nitrite in biology, nutrition and therapeutics. Nat Chem Biol. 2009;5(12): 865-869.
20. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996;380(6571): 221-226.
21. Gow AJ, Stamler JS. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature. 1998;391(6663): 169-173.
22. Basu S, et al. A novel role for cytochrome c: Efficient catalysis of S-nitrosothiol formation. Free Radic Biol Med. 2010;48(2): 255-263.
23. Inoue K, et al. Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J Biol Chem. 1999;274(38): 27069-27075.
24. Stamler JS, Hess DT. Nascent nitrosylases. Nat Cell Biol. 2010;12(11): 1024-1026.
25. Benhar M, Forrester MT, Stamler JS. Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol. 2009;10(10): 721-732.
26. Benhar M, Forrester MT, Hess DT, Stamler JS. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science. 2008;320(5879): 1050-1054.
27. Liu L, et al. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell. 2004;116(4): 617-628.
28. Whalen EJ, et al. Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell. 2007;129(3): 511-522.
29. Beigi F, et al. Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function. Proc Natl Acad Sci U S A. 2012;109(11): 4314-4319.
30. Jensen DE, Belka GK, Du Bois GC. S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme. Biochem J. 1998;331: 659-668.
31. Liu L, Hausladen A, Zeng M, Que L, Heitman J, Stamler JS. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature. 2001;410(6827): 490-494.
32. Sengupta R, Ryter SW, Zuckerbraun BS, Tzeng E, Billiar TR, Stoyanovsky DA. Thioredoxin catalyzes the denitrosation of low-molecular mass and protein S-nitrosothiols. Biochemistry. 2007; 46(28): 8472-8483.
33. Bateman RL, Rauh D, Tavshanjian B, Shokat KM. Human carbonyl reductase 1 is an S-nitrosoglutathione reductase. J Biol Chem. 2008; 283(51): 35756-35762.
34. Ozawa K, et al. S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. Mol Cell. 2008;31(3): 395-405.
35. Lima B, et al. Endogenous S-nitrosothiols protect against myocardial injury. Proc Natl Acad Sci U S A. 2009;106(15): 6297-6302.
36. Wu C, et al. Distinction of thioredoxin transnitrosylation and denitrosylation target proteins by the ICAT quantitative approach. J Proteomics. 2011;74(11): 2498-2509.
37. Seth D, Stamler JS. The SNO-proteome: causation and classifications. Curr Opin Chem Biol. 2011;15(1): 129-136.
38. Snyder EM, Johnson BD, Joyner MJ. Genetics of beta2-adrenergic receptors and the cardiopulmonary response to exercise. Exerc Sport Sci Rev. 2008;36(2): 98-105.
39. Que LG, et al. Protection from experimental asthma by an endogenous bronchodilator. Science. 2005;308(5728): 1618-1621.
40. Berthiaume Y, Matthay MA. Alveolar edema fluid clearance and acute lung injury. Respir Physiol Neurobiol. 2007;159(3): 350-359.
41. Baloglu E, Reingruber T, Bärtsch P, Mairbäurl H. β2-Adrenergics in hypoxia desensitize receptors but blunt inhibition of reabsorption in rat lungs. Am J Respir Cell Mol Biol. 2011;45(5): 1059-1068.
42. Weisbrod CJ, Minson CT, Joyner MJ, Halliwill Jr. Effects of regional phentolamine on hypoxic vasodilatation in healthy humans. J Physiol. 2001; 537(pt 2): 613-621.
43. Xie L, et al. Oxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL. Sci Signal. 2009;2(78):ra33.
44. Naghshin J, et al. Chronic intermittent hypoxia increases left ventricular contractility in C57BL/6J mice. J Appl Physiol. 2009;107(3): 787-793.
45. Whalen EJ, Johnson AK, Lewis SJ. Beta-adrenoceptor dysfunction after inhibition of NO synthesis. Hypertension. 2000;36(3): 376-382.
46. Wang G, Moniri NH, Ozawa K, Stamler JS, Daaka Y. Nitric oxide regulates endocytosis by S-nitrosylation of dynamin. Proc Natl Acad Sci U S A. 2006;103(5): 1295-1300.
47. Liu S, Premont RT, Kontos CD, Zhu S, Rockey DC. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat Med. 2005;11(9): 952-958.
48. Smith BC, Fernhoff NB, Marletta MA. Mechanism and kinetics of inducible nitric oxide synthase auto-S-nitrosation and inactivation. Biochemistry. 2012;51(5): 1028-1040.
49. Ravi K, Brennan LA, Levic S, Ross PA, Black SM. S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proc Natl Acad Sci U S A. 2004;101(8): 2619-2624.
50. Rassaf T, et al. Positive effects of nitric oxide on left ventricular function in humans. Eur Heart J. 2006;27(14): 1699-1705.
51. Arena R, Sietsema KE. Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation. 2011;123(6): 668-680.
52. Casey DP, Joyner MJ. Local control of skeletal muscle blood flow during exercise: influence of available oxygen. J Appl Physiol. 2011;111(6): 1527-1538.
53. Casey DP, Curry TB, Wilkins BW, Joyner MJ. Nitric oxide-mediated vasodilation becomes independent of beta-adrenergic receptor activation with increased intensity of hypoxic exercise. J Appl Physiol. 2011;110(3): 687-694.
54. Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature. 2001;409(6820): 622-626.
55. Sun QA, et al. Oxygen-coupled redox regulation of the skeletal muscle ryanodine receptor-Ca2+ release channel by NADPH oxidase 4. Proc Natl Acad Sci U S A. 2011;108(38): 16098-16103.
56. Eu JP, et al. Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. Proc Natl Acad Sci U S A. 2003;100(25): 15229-15234.
57. Sun J, Xu L, Eu JP, Stamler JS, Meissner G. Nitric oxide, NOC-12, and S-nitrosoglutathione modulate the skeletal muscle calcium release channel/ryanodine receptor by different mechanisms. An allosteric function for O2 in S-nitrosylation of the channel. J Biol Chem. 2003;278(10): 8184-8189.
58. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415(6868): 198-205.
59. Sun J, Xin C, Eu JP, Stamler JS, Meissner G. Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci U S A. 2001;98(20): 11158-11162.
60. Eu JP, Sun J, Xu L, Stamler JS, Meissner G. The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions. Cell. 2000;102(4): 499-509.
61. Xu L, Eu JP, Meissner G, Stamler JS. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science. 1998;279(5348): 234-237.
62. Sun J, Yamaguchi N, Xu L, Eu JP, Stamler JS, Meissner G. Regulation of the cardiac muscle ryanodine receptor by O(2) tension and S-nitrosoglutathione. Biochemistry. 2008;47(52): 13985-13990.
63. Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev. 2001;81(1): 209-237.
64. Bellinger AM, et al. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med. 2009;15(3): 325-330.
65. Durham WJ, et al. RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. Cell. 2008;133(1): 53-65.
66. Bellinger AM, et al. Remodeling of ryanodine receptor complex causes "leaky" channels: a molecular mechanism for decreased exercise capacity. Proc Natl Acad Sci U S A. 2008;105(6): 2198-2202.
67. Poole DC, Hirai DM, Copp SW, Musch TI. Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance. Am J Physiol Heart Circ Physiol. 2012;302(5):H1050-H1063.
68. Middlekauff HR. Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail. 2010;3(4): 537-546.
69. Kornberg MD, et al. GAPDH mediates nitrosylation of nuclear proteins. Nat Cell Biol. 2010; 12(11): 1094-1100.
70. Colussi C, et al. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A. 2008;105(49): 19183-19187.
71. Cacchiarelli D, et al. MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab. 2010;12(4): 341-351.
72. Trivedi CM, et al. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med. 2007;13(3): 324-331.
73. Gonzalez DR, Beigi F, Treuer AV, Hare JM. Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proc Natl Acad Sci U S A. 2007;104(51): 20612-20617.
74. Burger DE, et al. Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice. Circulation. 2009;120(14): 1345-1354.
75. Sun J, Morgan M, Shen RF, Steenbergen C, Murphy E. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res. 2007;101(11): 1155-1163.
76. Clementi E, Brown GC, Feelisch M, Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci U S A. 1998;95(13): 7631-7636.
77. Hare JM, Stamler JS. NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest. 2005;115(3): 509-517.
78. Ross JM, Fairchild HM, Weldy J, Guyton AC. Autoregulation of blood flow by oxygen lack. Am J Physiol. 1962;202: 21-24.
79. Roach RC, Koskolou MD, Calbet JA, Saltin B. Arterial O2 content and tension in regulation of cardiac output and leg blood flow during exercise in humans. Am J Physiol. 1999;276(2 pt 2):H438-H445.
80. Gonzalez-Alonso J, Richardson RS, Saltin B. Exercising skeletal muscle blood flow in humans responds to reduction in arterial oxyhaemoglobin, but not to altered free oxygen. J Physiol. 2001;530(pt 2): 331-341.
81. Singel DJ, Stamler JS. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu Rev Physiol. 2005;67: 99-145.
82. Doctor A, et al. Hemoglobin conformation couples erythrocyte S-nitrosothiol content to O2 gradients. Proc Natl Acad Sci U S A. 2005;102(16): 5709-5714.
83. Janocha AJ, et al. Nitric oxide during altitude acclimatization. N Engl J Med. 2011;365(20): 1942-1944.
84. Sartori C, et al. Selected contribution: long-term effects of beta(2)-adrenergic receptor stimulation on alveolar fluid clearance in mice. J Appl Physiol. 2002;93(5): 1875-1880.
85. Deem S, Bishop MJ, Alberts MK. Effect of anemia on intrapulmonary shunt during atelectasis in rabbits. J Appl Physiol. 1995;79(6): 1951-1957.
86. Deem S, Swenson ER, Alberts MK, Hedges RG, Bishop MJ. Red-blood-cell augmentation of hypoxic pulmonary vasoconstriction: hematocrit dependence and the importance of nitric oxide. Am J Respir Crit Care Med. 1998;157(4 pt 1): 1181-1186.
87. Uncles DR, Daugherty MO, Frank DU, Roos CM, Rich GF. Nitric oxide modulation of pulmonary vascular resistance is red blood cell dependent in isolated rat lungs. Anesth Analg. 1996;83(6): 1212-1217.
88. Weissmann N, Grimminger F, Walmrath D, Seeger W. Hypoxic vasoconstriction in buffer-perfused rabbit lungs. Respir Physiol. 1995;100(2): 159-169.
89. Han TH, Pelling A, Jeon TJ, Gimzewski JK, Liao JC. Erythrocyte nitric oxide transport reduced by a submembrane cytoskeletal barrier. Biochim Biophys Acta. 2005;1723(1-3): 135-142.
90. Han TH, et al. Regulation of nitric oxide consumption by hypoxic red blood cells. Proc Natl Acad Sci U S A. 2003;100(21): 12504-12509.
91. Huang KT, Huang Z, Kim-Shapiro DB. Nitric oxide red blood cell membrane permeability at high and low oxygen tension. Nitric Oxide. 2007;16(2): 209-216.
92. Jourd'heuil D, Gray L, Grisham MB. S-nitrosothiol formation in blood of lipopolysaccharide-treated rats. Biochem Biophys Res Commun. 2000;273(1): 22-26.
93. Crawford JH, Chacko BK, Pruitt HM, Piknova B, Hogg N, Patel RP. Transduction of NO-bioactivity by the red blood cell in sepsis: novel mechanisms of vasodilation during acute inflammatory disease. Blood. 2004;104(5): 1375-1382.
94. Deem S, et al. Pulmonary vascular effects of red blood cells containing S-nitrosated hemoglobin. Am J Physiol Heart Circ Physiol. 2004;287(6):H2561- H2568.
95. Crawford JH, et al. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood. 2006;107(2): 566-574.
96. McMahon TJ, et al. A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. Proc Natl Acad Sci U S A. 2005;102(41): 14801-14806.
97. Stevenson LW. Design of therapy for advanced heart failure. Eur J Heart Fail. 2005;7(3): 323-331.
98. Datta B, et al. Red blood cell nitric oxide as an endocrine vasoregulator: a potential role in congestive heart failure. Circulation. 2004;109(11): 1339-1342.
99. Gow AJ, Chen Q, Hess DT, Day BJ, Ischiropoulos H, Stamler JS. Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J Biol Chem. 2002;277(12): 9637-9640.
100. Kluge I, Gutteck-Amsler U, Zollinger M, Do KQ. S-nitrosoglutathione in rat cerebellum: identification and quantification by liquid chromatography-mass spectrometry. J Neurochem. 1997;69(6): 2599-2607.
101. Lipton AJ, Johnson MA, Macdonald T, Lieberman MW, Gozal D, Gaston B. S-nitrosothiols signal the ventilatory response to hypoxia. Nature. 2001;413(6852): 171-174.
102. Gaston B, et al. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci U S A. 1993;90(23): 10957-10961.
103. Gaston B, Singel D, Doctor A, Stamler JS. S-nitrosothiol signaling in respiratory biology. Am J Respir Crit Care Med. 2006;173(11): 1186-1193.
104. Kasai T, Bradley TD. Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J Am Coll Cardiol. 2011;57(2): 119-127.
105. Wong E, Selig S, Hare DL. Respiratory muscle dysfunction and training in chronic heart failure. Heart Lung Circ. 2011;20(5): 289-294.
106. Li F, et al. Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell. 2007;26(1): 63-74.
107. Palmer LA, et al. S-nitrosothiols signal hypoxia- mimetic vascular pathology. J Clin Invest. 2007;117(9): 2592-2601.
108. Chowdhury R, et al. Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1). J Mol Biol. 2011;410(2): 268-279.
109. Berchner-Pfannschmidt U, Yamac H, Trinidad B, Fandrey J. Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2. J Biol Chem. 2007;282(3): 1788-1796.
110. Tsui AK, et al. Priming of hypoxia-inducible factor by neuronal nitric oxide synthase is essential for adaptive responses to severe anemia. Proc Natl Acad Sci U S A. 2011;108(42): 17544-17549.
111. Rao SV, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol. 2005;96(9): 1200-1206.
112. Kinnaird TD, et al. Incidence, predictors, and prognostic implications of bleeding and blood transfu sion following percutaneous coronary interventions. Am J Cardiol. 2003;92(8): 930-935.
113. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345(17): 1230-1236.
114. van Veldhuisen DJ, Anker SD, Ponikowski P, Macdougall IC. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol. 2011;8(9): 485-493.
115. Taylor AL, et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351(20): 2049-2057.
116. Cohn JN, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986;314(24): 1547-1552.
117. Maroko PR, Braunwald E. Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion. Acta Med Scand Suppl. 1976;587: 125-136.
118. Borer JS, et al. Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarction. N Engl J Med. 1975;293(20): 1008-1012.
119. Rao SV, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004;292(13): 1555-1562.
120. Hill SR, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2002; (2):CD002042.
121. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116(22): 2544-2552.
122. Kim P, Dixon S, Eisenbrey AB, O'Malley B, Boura J, O'Neill W. Impact of acute blood loss anemia and red blood cell transfusion on mortality after percutaneous coronary intervention. Clin Cardiol. 2007;30(10 suppl 2):II35-II43.
123. Reynolds JD, Ahearn GS, Angelo M, Zhang J, Cobb F, Stamler JS. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A. 2007;104(43): 17058-17062.
124. Bennett-Guerrero E, et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A. 2007;104(43): 17063-17068.
125. Kiraly LN, Underwood S, Differding JA, Schreiber MA. Transfusion of aged packed red blood cells results in decreased tissue oxygenation in critically injured trauma patients. J Trauma. 2009; 67(1): 29-32.
126. Shimazutsu K, et al. Inclusion of a nitric oxide congener in the insufflation gas repletes S-nitrosohemoglobin and stabilizes physiologic status during prolonged carbon dioxide pneumoperitoneum. Clin Transl Sci. 2009;2(6): 405-412.
127. Metzen E, et al. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol Biol Cell. 2003;14(8): 3470-3481.